14 May 2014, BioSpectrum Bureau , BioSpectrum
Singapore: Global Mobile health (mhealth) market is expected to soar by 2018 with a CAGR of 25.5 percent experts have said. The major drivers of this market are the growing adoption of smartphones, high penetration of 3G and 4G networks even in rural areas, advanced mobile connectivity and the myriad constraints felt by healthcare systems of developing nations, with regard to high population growth, high burden of disease prevalence, low health care workforce, and a large numbers of rural inhabitants.
Several mhealth apps such as cardiac monitoring, diabetes management, exercise, weight loss, women's health, sleep, and meditation help underdeveloped countries such as Africa, which have a low patient-doctor ratio in management of disease and regulation. North America holds the largest share of the Global mHealth market in 2013. UK, India, China, Japan, Africa, and Australia are the major contributors followed by Europe and Asia that will witness potential growth due to significant adoption of mobile health technology.
Various healthcare and non-healthcare sectors such as Philips (The Netherlands), Medtronic (US), Nike (US), Omron (Japan), Alere (US) AT and T (US), Qualcomm (US), Cerner (US), and Diversinet (Canada) comprise the mhealth industry.